Systemic lupus erythematosus associated with ANCA-associated vasculitis: An overlapping syndrome?

Rheumatology International

Volumn 32, Issue 10, 2012, Pages 3285-3290

  Hervier, B ^a,b   Hamidou, M ^b   Haroche, J ^a   Durant, C ^b   Mathian, A ^a   Amoura, Z ^a  

^a National Reference Centre for Lupus and Antiphospholipid Syndrome   (France)

^b HÔTEL DIEU   (France)

Author keywords

ANAs; ANCA associated vasculitis; ANCAs; Systemic lupus erythematosus

Indexed keywords

COTRIMOXAZOLE; CREATININE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID; THALIDOMIDE;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; AWARENESS; CASE REPORT; CREATININE BLOOD LEVEL; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; INFLAMMATION; KIDNEY BIOPSY; LOW DRUG DOSE; LUNG HEMORRHAGE; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL; VASCULITIS;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ARTHRITIS; AUTOIMMUNITY; BIOLOGICAL MARKERS; FEMALE; HEMORRHAGE; HUMANS; KIDNEY DISEASES; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS; SEROSITIS; SEVERITY OF ILLNESS INDEX; SYNDROME; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 84867898532     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2055-z     Document Type: Article

References (28)

1. La Cava A (2009) Lupus and T cells. Lupus 18(3):196-201
2. Renaudineau Y, Pers JO, Bendaoud B, Jamin C, Youinou P (2004) Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 3(7-8):516-523
3. Falk RJ, Jennette JC (2004) Thoughts about the classification of small vessel vasculitis. J Nephrol 17(Suppl 8):S3-S9
4. Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12(9):651-658
5. Lee SS, Lawton JW, Chak W (1991) Distinction between antinuclear antibody and P-ANCA. J Clin Pathol 44(11):962-963
6. Arahata H, Migita K, Izumoto H, Miyashita T, Munakata H, Nakamura H, Tominaga M, Origuchi T, Kawabe Y, Hida A, Taguchi T, Eguchi K (1999) Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. Clin Rheumatol 18(1):77-81
7. Cavagna L, Caporali R, Esposito C, Augetti C, Epis O, Montecucco C (2007) Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. Scand J Rheumatol 36(1):74-76
8. Hirai Y, Iyoda M, Shibata T, Ashikaga E, Hosaka N, Suzuki H, Nagai H, Mukai M, Honda H, Kuroki A, Kitazawa K, Akizawa T (2008) Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clin Exp Nephrol 12(5):393-397
9. Kobayashi S, Inokuma S (2009) Intrapulmonary haemorrhage in collagen-vascular diseases includes a spectrum of underlying conditions. Intern Med 48(11):891-897
10. Nasr SH, D'Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, Hazlett SM, Pursell RN, Caputo C, Markowitz GS (2008) Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol 3(3):682-690
11. Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K (1997) Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 16(1):70-75
12. Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, Kallenberg CG (1996) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 35(7):625-631
13. Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307-317
14. Cambridge G, Wallace H, Bernstein RM, Leaker B (1994) Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 33(2):109-114
15. Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, De Ramon GE, Fernandez-Nebro A, Houssiau F, Jedryka-Goral A, Mathieu A, Papasteriades C, Piette JC, Scorza R, Smolen J (1998) Anti-neutrophil cytoplasmic anti bodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European concerted action on the immunogenetics of SLE. Clin Exp Rheumatol 16(5):541-546
16. Manolova I, Dancheva M, Halacheva K (2001) Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int 20(5):197-204
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271-1277
18. Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS (2000) Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20(1):57-63
19. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318(25):1651-1657
20. Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH, Chau KF (1992) Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 31(10):669-673
21. Marshall S, Dressler R, D'Agati V (1997) Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 29(1):119-124
22. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866-873
23. Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A (1990) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 81(3):380-383
24. Akhtar M, al Dalaan A, el Ramahi KM (1994) Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis 23(2):320-325
25. Lamprecht P (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141(2):201-210
26. Masutani K, Tokumoto M, Nakashima H, Tsuruya K, Kashiwagi M, Kudoh Y, Fukuda K, Kanai H, Akahoshi M, Otsuka T, Hirakata H, Iida M (2003) Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol 59(6):395-405
27. Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4(8):542-548
28. Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson B (2003) Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signalling. Arthritis Rheum 48(3):746-756